Ez Aldeen Esawi
Higher Degree by Research Candidate
South Australian Immunogenomics Cancer Institute
Faculty of Health and Medical Sciences
-
Appointments
Date Position Institution name 2019 - 2023 Research assistance University of Jordan 2017 - 2023 Medical laboratory technologist King Hussein Cancer Center -
Language Competencies
Language Competency Arabic Can read, write, speak, understand spoken and peer review English Can read, write, speak and understand spoken -
Education
Date Institution name Country Title 2018 - 2021 University of Jordan Jordan M.Sc. Medical laboratory sciences 2013 - 2017 Hashemite University Jordan BSc -
Research Interests
-
Journals
Year Citation 2023 Nsairat, H., Alshaer, W., Odeh, F., Esawi, E., Khater, D., Bawab, A. A., . . . Mubarak, M. S. (2023). Recent advances in using liposomes for delivery of nucleic acid-based therapeutics. OpenNano, 11, 100132.
2023 Alshaer, W., Nsairat, H., Lafi, Z., Hourani, O. M., Al-Kadash, A., Esawi, E., & Alkilany, A. M. (2023). Quality by Design Approach in Liposomal Formulations: Robust Product Development. Molecules, 28(1), 19 pages.
Scopus5 WoS4 Europe PMC22023 Abuarqoub, D., Mahmoud, N., Alshaer, W., Mohammad, M., Ibrahim, A. A., Al-Mrahleh, M., . . . Awidi, A. (2023). Biological Performance of Primary Dental Pulp Stem Cells Treated with Gold Nanoparticles. Biomedicines, 11(9), 1-15.
2023 COVID-19 Host Genetics Initiative. (2023). A second update on mapping the human genetic architecture of COVID-19.. Nature, 621(7977), E7-E26.
Europe PMC12022 Al-Azzawi, H., Alshaer, W., Esawi, E., Lafi, Z., Abuarqoub, D., Zaza, R., . . . Awidi, A. (2022). Multifunctional nanoparticles recruiting hyaluronic acid ligand and polyplexes containing low molecular weight protamine and ATP-Sensitive DNA motif for doxorubicin delivery. Journal of Drug Delivery Science and Technology, 69, 11 pages.
2022 The COVID-19 Host Genetics Initiative., & Ganna, A. (2022). A second update on mapping the human genetic architecture of COVID-19.
2021 Sweidan, N., Esawi, E., Ismail, M., & Alshaer, W. (2021). Anticancer Cardenolides from the aerial parts of Calortopis procera. Zeitschrift fur Naturforschung - Section C Journal of Biosciences, 76(5), 243-250.
Scopus2 WoS1 Europe PMC12021 Mahmoud, I. S., Hatmal, M. M., Abuarqoub, D., Esawi, E., Zalloum, H., Wehaibi, S., . . . Alshaer, W. (2021). 1,4-Naphthoquinone Is a Potent Inhibitor of IRAK1 Kinases and the Production of Inflammatory Cytokines in THP-1 Differentiated Macrophages. ACS OMEGA, 6(39), 25299-25310.
WoS5 Europe PMC52021 Esawi, E., Alshaer, W., Mahmoud, I. S., Alqudah, D. A., Azab, B., & Awidi, A. (2021). Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells. International Journal of Molecular Sciences, 22(23), 12940.
WoS3 Europe PMC22020 Odeh, F., Nsairat, H., Alshaer, W., Ismail, M. A., Esawi, E., Qaqish, B., . . . Ismail, S. I. (2020). Aptamers Chemistry: Chemical Modifications and Conjugation Strategies. MOLECULES, 25(1), 51 pages.
WoS154 Europe PMC75 -
Book Chapters
Year Citation 2023 Esawi, E., Nsairat, H., Mahmoud, I. S., Lafi, Z., Al-Kadash, A., Al-Ragheb, B. A., . . . Alhaer, W. (2023). Clinical use and future perspective of aptamers. In Aptamers Engineered Nanocarriers for Cancer Therapy (pp. 481-520). Elsevier.
2022 Nsairat, H., Alshaer, W., Mahmoud, I. S., Ismail, M. A., Esawi, E., Alsotari, S., & Ismail, S. I. (2022). Aptamers in Theranostic Bionanomaterials. In Bionanotechnology: Next-Generation Therapeutic Tools (pp. 130-158). BENTHAM SCIENCE PUBLISHERS.
Connect With Me
External Profiles
